HRT Financial’s ESSA Pharma EPIX Stock Holding History

HRT Financial’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-53,443	Closed	-$168K	–	3016
2022 Q2	$168K	Buy	+53,443	New	+$299K	﹤0.01%	2299
2021 Q4	–	Sell	-74,187	Closed	-$593K	–	3417
2021 Q3	$593K	Buy	+74,187	New	+$1.18M	﹤0.01%	1832
2021 Q2	–	Sell	-24,616	Closed	-$715K	–	3030
2021 Q1	$715K	Buy	+24,616	New	+$572K	0.01%	1513

Other funds holding EPIX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return